Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system

অনুরূপ উপাদানগুলি

• Real-world safety of Symdeko: insights from the food and drug administration adverse event reporting system
  অনুযায়ী: Su Wei, অন্যান্য
  প্রকাশিত: (2025-10-01)
• Safety assessment of gemtuzumab ozogamicin: real-world adverse event analysis based on the FDA Adverse Event Reporting System
  অনুযায়ী: Xuexue Liu, অন্যান্য
  প্রকাশিত: (2025-09-01)
• Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
  অনুযায়ী: Zhuomiao Lin, অন্যান্য
  প্রকাশিত: (2025-08-01)
• Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database
  অনুযায়ী: Yu Liu, অন্যান্য
  প্রকাশিত: (2025-08-01)
• Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database
  অনুযায়ী: Jintuo Zhou, অন্যান্য
  প্রকাশিত: (2025-09-01)